Relation between clinical outcome and the percentage of CD4⁺ cells in infused CTL lines. A higher percentage of PTLD patients responded to CTL therapy when the infused CTL lines contained a higher percentage of CD4⁺ cells. This trend was statistically significant both at 5 weeks (♦) and at 6 months (◇) (P = .001 and P = .001, respectively).